3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Observational
2
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
67
Polycystic Ovary Syndrome
3
Neoplasms, Hormone-Dependent
3
Neoplasm Metastasis
2
Carcinoma, Lobular
2
Carcinoma, Intraductal, Noninfiltrating
2
Carcinoma, Ductal, Breast
2
Breast Diseases
2
Breast Cancer Female
2
Advanced Breast Cancer
2
Sexuality
1
Sexual Dysfunctions, Psychological
1
Osteoporosis
1
Luminal B/HER2-negative Breast Cancer
1
Leiomyoma
1
Infertility
1
Hot Flashes
1
Hormone Receptor Positive Breast Carcinoma
1
Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer
1
HR+/HER2- Early Breast Cancer
1
HR+/HER2+ Early Breast Cancer
1
Fractures, Bone
1
Estrogen Receptor and/or Progesterone Receptor Positive
1
Endometrial Stromal Tumors
1
Endometrial Neoplasms
1
Bulbo-Spinal Atrophy, X-Linked
1
Breast Neoplasms, Male
1
Breast Carcinoma In Situ
1
Breast Cancer Metastatic
1
Bone Diseases, Metabolic
1
Interventions
Surveys and Questionnaires
3
Testosterone
2
Fatty Acids, Omega-3
2
Exercise
2
Educational Status
2
Acupuncture Therapy
2
methyl hydroxyethyl cellulose
1
guizhi-shaoyao-zhimu decoction
1
canakinumab
1
Yoga
1
Walking
1
Vitamin B 12
1
Therapeutics
1
Occupational Therapy
1
Letrozole
1
Hyaluronic Acid
1
Glucosamine
1
Glucaric Acid
1
Gabapentin
1
Fish Oils
1
Docosahexaenoic Acids
1
Diphosphonates
1
Diet Therapy
1
Denosumab
1
Curcumin
1
Chondroitin Sulfates
1
Chondroitin
1
Cholecalciferol
1
Cannabidiol
1
Calcium Gluconate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Arthralgia
×
Aromatase Inhibitors
×
Clear all
NCT01612728
2013-02-12
AIA
Baylor Breast Care Center
Phase 2
Withdrawn